89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
10.00
+0.06 (0.60%)
At close: Jun 18, 2025, 4:00 PM
9.95
-0.05 (-0.50%)
After-hours: Jun 18, 2025, 7:40 PM EDT
89bio Stock Forecast
Stock Price Forecast
The 8 analysts that cover 89bio stock have a consensus rating of "Strong Buy" and an average price target of $26.43, which forecasts a 164.3% increase in the stock price over the next year. The lowest target is $11 and the highest is $49.
Price Target: $26.43 (+164.3%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 14, 2025.
Analyst Ratings
The average analyst rating for 89bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 4 |
| Buy | 2 | 3 | 3 | 3 | 3 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 10 | 10 | 10 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Initiates $11 | Hold | Initiates | $11 | +10.00% | Mar 14, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +150.00% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $29 → $21 | Strong Buy | Reiterates | $29 → $21 | +110.00% | Feb 28, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 4, 2025 |
| UBS | UBS | Strong Buy Maintains $25 → $38 | Strong Buy | Maintains | $25 → $38 | +280.00% | Jan 31, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.01B
Revenue Next Year
n/a
EPS This Year
-2.13
from -3.51
EPS Next Year
-2.28
from -2.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 21.2M | 98.7M | ||
| Avg | n/a | 2.9M | 34.4M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 3,253.7% | ||
| Avg | - | - | 1,067.4% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.82 | -1.31 | -1.49 | ||
| Avg | -2.13 | -2.28 | -2.21 | ||
| Low | -2.40 | -3.22 | -3.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.